ApexQubit

ApexQubit

A company developing a platform for drug discovery using quantum computing and artificial intelligence.

ApexQubit is a startup company based in Riga, Latvia developing quantum computing and artificial intelligence software for drug discovery. Founded in 2018 by Denis Farsonov and Nihil Khaine, as of January 2020 Apex Qubit has disclosed $45K in funding from pre-seed rounds. ApexQuibit is funded by Overkill Ventures and HealthInc a health tech accelerator run by the Amsterdam Health & Technology Institute.

ApexQubit aims to improve the drug engineering process using quantum computing and AI to analyze different combinations of chemical compounds significantly faster than current classical computers can and identify higher-quality drug candidates. The company aims to deliver SaaS and will target their first clients in Europe and North America.

The company is interested in the optimization of CRISPR-cas systems, the design of protein-based therapeutics, and the engineering of universal immune cells. ApexQubit is interested in gene activation and repression modes, to provide a better ability to avoid an immune response, and to further the process of gene editing precision. The company is also interested in the generation of new small and mid-sized molecules for specific protein-based diseases and the screening and prediction of binding affinties. ApexQubit is also interested in the design of universal immune cells with adaptable specificty for tumor prenetration and resistance to solid tumors.

Timeline

People

Name
Role
LinkedIn

Andris Ambainis

Scientific Advisor

Barry Sanders

Scientific Advisor & Board Member

Marcin J. Skwark

Data Scientist & Scientific Advisor

Further reading

Title
Author
Link
Type
Date

ApexQubit | Harnessing frontier technologies for better health for humanity

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

ApexQubit

Denis Farnosov

Berkeley, California, United States

Quantum Computing for Drug Development

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.